Tiny Particles, Big Health Impacts Authors: John R. Balmes, Nadia N. Hansel Published: 2024 Considerable public attention is given to the health impacts of outdoor exposure to particulate matter ≤2.5 μm in aerodynamic diameter (PM2.5). Robust associations have consistently been observed between ambient concentrations of PM2.5 and cardiopulmonary morbidity and mortality globally (1). As such, PM2.5 is a significant contributor to the global burden of disease and a focus of air quality regulation in many countries. PM2.5 encompasses all particles smaller than 2.5 μm, with the ultrafine fraction constituting particles <0.1 μm or <100 nm. The primary source of ambient ultrafine particles (UFPs) is combustion, particularly from roadway traffic. Although UFPs contribute minimally to overall ambient particle mass in urban environments, they make up the majority of total particle number. Once inhaled and deposited in the deep lung, these tiny particles can cross the alveolar-capillary membrane and enter the systemic circulation. Because of their high number, inhaled UFPs have a large surface area for chemical reactivity with body molecules. In vitro and animal studies have documented substantial toxicity of UFPs, including oxidative stress, inflammation, tissue injury, and DNA damage (2). Air quality regulation in many high-income countries has led to substantial reductions in ambient PM2.5 concentrations, but this has not necessarily caused reductions in UFPs. A major reason for the lack of direct regulation of UFPs is the relative lack of data supporting human health effects from real-world exposures. Unfortunately, epidemiological studies of UFPs are hard to conduct because there is no network of regulatory monitors to measure ambient concentrations, and monitoring for research purposes requires expensive equipment. In this context, the study by Lloyd and colleagues (pp. 1338–1347) in this issue of the Journal represents a crucial advancement in our understanding of the potential public health impact of ambient UFPs (3). The authors studied exposure to outdoor UFPs within a large, population-based cohort from Montreal and Toronto, Canada, spanning 2001 to 2016. They found that long-term exposure to UFPs was associated with an increased risk of nonaccidental and cause-specific mortality, with the greatest risk observed for respiratory-related deaths. Lloyd and colleagues estimated that UFP pollution could be responsible for 1,100 nonaccidental deaths per year in these cities. They also found that long-term exposure to ozone was also positively associated with all mortality outcomes except lung cancer, supporting previous research. As noted, there is no historical record of UFP air quality monitoring in Canada (or the United States) comparable to the data that exist for PM2.5. Therefore, Lloyd and colleagues had to employ innovative methods to assess UFP exposure in Montreal and Toronto for the study period. They used models of pollutant exposure based on large-scale mobile monitoring campaigns conducted across each city over a 1-year period between 2020 and 2021. These models combined land use regression and machine learning techniques that explained the majority of spatial variations in UFPs and other pollutants across each city. To estimate UFP concentrations for the years 1998–2016, they then used historical values for traffic emissions based on measured nitrogen oxide concentrations in a process known as “back-casting.” Exposures were assigned on the basis of residential Canadian postal codes (approximately one city block face) using a 3-year moving average with a 1-year lag to ensure that estimates of long-term exposures preceded health outcomes. Cox proportional hazards models were then used to estimate hazard ratios for mortality outcomes associated with each 10,000 particles/cm3 increase in annual average outdoor UFP concentration. The Lloyd and colleagues study has many strengths, including a large sample size (N > 1.3 million), careful modeling of both UFPs and potentially confounding gaseous pollutants, reliable mortality data from Canadian administrative records, and appropriate statistical analysis that includes adjustment for UFP size. Despite these strengths, the study also has several weaknesses. The most salient of these is possible exposure misclassification from both the back-casting of UFP concentrations rather than direct measurement and the assignment of exposure on the basis of residential postal codes, which does not account for time spent outside these areas by participants. Although the exposure models incorporated historical traffic data to account for long-term trends in UFP emissions, they may not have fully captured other changes in emissions over the study period. In addition, the cohort lacked individual-level data for mortality risk factors such as smoking and body mass index. As mentioned, much of what we know about possible health effects from UFP exposure comes from research done on animals, showing strong and consistent evidence indicating that long-term exposure to UFPs can have negative effects on the brain and the nervous and respiratory systems (4). To provide an adequate basis for regulatory action on UFPs, there is a pressing need for more human population data. No single epidemiological study alone can compel governmental agencies to regulate UFPs, but this study adds to an expanding body of evidence indicating that current UFP concentrations have adverse public health effects. The existing evidence suggests adverse short-term associations with inflammatory and cardiovascular changes, which may occur independently of other pollutants (5, 6). There is a paucity of studies on long-term effects of UFP exposure, of which the Lloyd and colleagues study helps to fill this gap. A study from the Netherlands using high spatial resolution methods for long-term UFP exposure assessment reported mortality effects similar to those observed in the Lloyd and colleagues study (7). In addition, two studies from Denmark also using high spatial resolution UFP exposure modeling found positive associations with long-term exposures and nonmortality outcomes (8, 9). Given the toxicological profile of UFPs and the growing epidemiological evidence linking both short- and long-term exposures to public health harm, it is essential that governmental agencies responsible for air quality develop a regulatory approach to this pollutant. To improve our understanding of population exposures and facilitate essential epidemiological research, networks for monitoring UFP should be established. Although current UFP monitoring devices are prohibitively expensive for widespread use at high spatial resolution, distributing low-cost nitrogen oxide sensors in conjunction with strategically placed high-quality UFP monitoring devices could provide valuable data (10).